Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Carcinoma. Found 26 abstracts

no pagination
Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH. Robotic Partial Nephrectomy versus Minimally Invasive Radical Nephrectomy for Clinical T2a Renal Mass: A Propensity Score Matched Comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. BJU international. 2020 Mar 31;.
Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Bartel MJ, Puri R, Brahmbhatt B, Chen WC, Kim D, Simons-Linares CR, Stauffer JA, Buchanan MA, Bowers SP, Woodward TA, Wallace MB, Raimondo M, Asbun HJ. Endoscopic and surgical management of nonampullary duodenal neoplasms. Surgical endoscopy. 2018 Jun;32(6):2859-69.
Aggarwal C, Borghaei H. Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design. The oncologist. 2017 Apr 13;22(6):700-8.   PMCID: PMC5469580
Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, Zhang WJ, Li PD. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016 Sep 20;7(38):61741-54.   PMCID: PMC5308687
Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E. Breast cancer clinical characteristics and outcomes in Trinidad and Tobago. Journal of immigrant and minority health. 2015 Jun;17(3):765-72.
Haggerty AF, Mantia-Smaldone G, Siegelman E, Livolsi V, Tanyi J. Surgical diagnosis of stage I fallopian tube cancer in anti-Yo antibody paraneoplastic cerebellar degeneration. J Obstet Gynaecol. 2015 Jan;35(1):100-1.
Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, Radice P, Ramus SJ, Domchek SM, Nathanson KL, Lee A, Healey S, Nussbaum RL, Rebbeck TR, Arun BK, James P, Karlan BY, Lester J, Cass I, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Steele L, v OH, Ejlertsen B, Gerdes AM, Nielsen FC, Dennis J, Cunningham J, Hart S, Slager S, Osorio A, Benitez J, Duran M, Weitzel JN, Tafur I, Hander M, Peterlongo P, Manoukian S, Peissel B, Roversi G, Scuvera G, Bonanni B, Mariani P, Volorio S, Dolcetti R, Varesco L, Papi L, Tibiletti MG, Giannini G, Fostira F, Konstantopoulou I, Garber J, Hamann U, Donaldson A, Brewer C, Foo C, Evans DG, Frost D, Eccles D, Douglas F, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Ong KR, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Eeles R, Davidson R, Hodgson S, Ellis S, Godwin AK, Rhiem K, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher D, Sutter C, Steinemann D, Bogdanova-Markov N, Kast K, Varon-Mateeva R, Wang-Gohrke S, Gehrig A, Markiefka B, Buecher B, Lefol C, Stoppa-Lyonnet D, Rouleau E, Prieur F, Damiola F, Barjhoux L, Faivre L, Longy M, Sevenet N, Sinilnikova OM, Mazoyer S, Bonadona V, Caux-Moncoutier V, Isaacs C, Van Maerken T, Claes K, Piedmonte M, Andrews L, Hays J, Rodriguez GC, Caldes T, de la Hoya M, Khan S, Hogervorst FB, Aalfs CM, de Lange JL, Meijers-Heijboer HE, van der Hout AH, Wijnen JT, van Roozendaal KE, Mensenkamp AR, van den Ouweland AM, van Deurzen CH, van der Luijt RB, Olah E, Diez O, Lazaro C, Blanco I, Teule A, Menendez M, Jakubowska A, Lubinski J, Cybulski C, Gronwald J, Jaworska-Bieniek K, Durda K, Arason A, Maugard C, Soucy P, Montagna M, Agata S, Teixeira MR, Olswold C, Lindor N, Pankratz VS, Hallberg E, Wang X, Szabo CI, Vijai J, Jacobs L, Corines M, Lincoln A, Berger A, Fink-Retter A, Singer CF, Rappaport C, Kaulich DG, Pfeiler G, Tea MK, Phelan CM, Mai PL, Greene MH, Rennert G, Imyanitov EN, Glendon G, Toland AE, Bojesen A, Pedersen IS, Jensen UB, Caligo MA, Friedman E, Berger R, Laitman Y, Rantala J, Arver B, Loman N, Borg A, Ehrencrona H, Olopade OI, Simard J, Easton DF, Chenevix-Trench G, Offit K, Couch FJ, Antoniou AC. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2014 Jan;16(6):3416.   PMCID: PMC4406179
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2014 Jan;39(2):185-9.   PMCID: No NIH funding
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Med Dosim. 2014 Jan;39(2):185-9.
Simhan J, Canter D, Teper E, Smaldone MC, Patil N, Patchefsky A, Guttmann MC, Milestone B, Wong YN, Hicks LA, Uzzo RG, Kutikov A. Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout study. Urology. 2012 Feb;79(2):e19-20.   PMCID: not NIH funded
Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score. European Urology. 2011 Aug;60(2):241-8.   PMCID: PMC3124570
Plimack ER, Hudes GR. Selecting Targeted Therapies for Patients With Renal Cell Carcinoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):997-1007.   PMCID: not NIH funded
Balaburski GM, Dardes RC, Johnson M, Haddad B, Zhu F, Ross EA, Sengupta S, Klein-Szanto A, Liu H, Lee ES, Kim H, Jordan VC. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance. Int J Oncol. 2010 Aug;37(2):387-98.   PMCID: PMC3023309
Miller SM, Roussi P, Daly MB, Scarpato J. New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res. 2010 Nov;16(21):5094-106.   PMCID: Pmc3107031
Henske EP. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatric Nephrology. 2005 Jul;20(7):854-7.
Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. J Urol. 2003 Jun;169(6):2160-5.
Schilder RJ, Brady MF, Spriggs D, Shea T. Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study. Gynecol Oncol. 2003 Jan;88(1):3-8.
Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun. 2003 Apr 18;303(4):1169-78.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Carcinoma

Carcinoma Female Middle Aged pathology Adult metabolism Aged therapy surgery Breast Neoplasms Young Adult genetics Ovarian Neoplasms diagnosis Human radiotherapy Disease-Free Survival Cell Proliferation Thoracic Wall Treatment Outcome drug effects Local Neoplasm Recurrence trends drug therapy methods Radiation Dosage US Gov't Support-PHS Radiotherapy mortality Neoplasm Staging Breast cancer Risk Factors Male utilization blood Adenoma Disease Progression Mice adverse effects Signal Transduction immunology carcinoma therapeutic use Urothelium 80 and over Aged Modified Radical Mastectomy Progesterone Receptors Estrogen Receptors Dosimetry Intensity-Modulated Radiotherapy Non-US Gov't Support Combined Modality Therapy Imrt Neoadjuvant Therapy Selective Estrogen Receptor Modulators Paraneoplastic Cerebellar Degeneration me [Metabolism] LncRNA Estrogens renal cell Intercellular Signaling Peptides and Proteins RNA Interference Minimally-Invasive Surgery Xenograft Model Antitumor Assays randomized-trial statistics & numerical Antineoplastic Agents Alleles Ductal Carcinoma-Breast Urologic Neoplasms Up-Regulation mTOR pathway X-Ray Computed Tomography phase-iii trial Raloxifene Hydrochloride Melphalan education Lobular Carcinoma Overall Survival Mutation Neoplastic Stem Cells Estrogen Antagonists Glycolysis Digestive System Endoscopy Surgical resection Nonampullary duodenal neoplasms Vascular Endothelial Growth Factor A laparoscopic partial nephrectomy Middle Age Fatal Outcome Complications Choice Behavior Differential Diagnosis Multivariate Analysis glucose metabolism Peripheral Blood Stem Cell Transplantation Cisplatin Adrenal Cortex Neoplasms Surrogate endpoint Non-US Gov't Research Support kidney neoplasms radiography Cell Cycle Checkpoints Fallopian Tube Neoplasms Filgrastim Duodenal Neoplasms Renal Cell 2010 dermott df-v28 sunitinib Hormone Replacement Therapy Experimental Mammary Neoplasms Delayed Diagnosis Magnetic Resonance Imaging Proportional Hazards Models Tumor Biomarkers Length of Stay Genetic Vectors Registries Prostatic Neoplasms Tuberous Sclerosis Drug Interactions Trinidad and Tobago Follow-Up Studies Randomized Controlled Trials as Topic Endoscopic Mucosal Resection et [Etiology] Paclitaxel etiology Patient Education as Topic Endothelial Growth Factors biosynthesis cytology Protein Isoforms Contrast Media Radiotherapy Dosage ErbB-2 Receptor medullary Neoplastic Gene Expression Regulation Ovariectomy ge [Genetics] Urinary Bladder Neoplasms statistics & numerical data Cell Cycle Proteins Kidney Neoplasms Retrospective Studies Perioperative Care Nomograms Diffusion of Innovation Neoplasm Drug Resistance Cultured Tumor Cells
Last updated on Tuesday, August 11, 2020